• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

葛根素通过调节肝脂质蓄积、氧化应激和炎症改善大鼠非酒精性脂肪肝。

Puerarin ameliorates nonalcoholic fatty liver in rats by regulating hepatic lipid accumulation, oxidative stress, and inflammation.

机构信息

Beijing Key Laboratory of Functional Food from Plant Resources, College of Food Science and Nutritional Engineering, China Agricultural University, Beijing, China.

Clinical Laboratory Sciences Department, Turabah University College, Taif University, Taif, Saudi Arabia.

出版信息

Front Immunol. 2022 Jul 25;13:956688. doi: 10.3389/fimmu.2022.956688. eCollection 2022.

DOI:10.3389/fimmu.2022.956688
PMID:35958617
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9359096/
Abstract

Nonalcoholic fatty liver disease (NAFLD) has become one of the public health problems globally. The occurrence of NAFLD is usually accompanied by a series of chronic metabolic diseases, with a prevalence rate is 25.24% among adults worldwide. Therefore, NAFLD seriously affects the quality of life in patients and causes a large economic burden. It has been reported that puerarin has the function of lowering the serum lipids, but due to the complexity of NAFLD, the specific mechanism of action has not been clarified. The aim of this study was to evaluate the preventive or ameliorating effects of two doses of puerarin (0.11% and 0.22% in diet) on high-fat and high-fructose diet (HFFD)-induced NAFLD in rats. The rats were fed with HFFD-mixed puerarin for 20 weeks. The results showed that puerarin ameliorated the levels of lipids in the serum and liver. Further exploration of the mechanism found that puerarin ameliorated hepatic lipid accumulation in NAFLD rats by reducing the expression of , , , , , , , , , and and upregulating the expression of , , and . At the same time, after administration of puerarin, the levels of antioxidant markers (superoxide dismutase, glutathione peroxidase, and catalase) were significantly increased in the serum and liver, and the contents of serum and hepatic inflammatory factors (interleukin-18, interleukins-1β, and tumor necrosis factor α) were clearly decreased. In addition, puerarin could ameliorate the liver function. Overall, puerarin ameliorated HFFD-induced NAFLD by modulating liver lipid accumulation, liver function, oxidative stress, and inflammation.

摘要

非酒精性脂肪性肝病(NAFLD)已成为全球公共卫生问题之一。NAFLD 的发生通常伴随着一系列慢性代谢性疾病,全球成年人的患病率为 25.24%。因此,NAFLD 严重影响患者的生活质量,并造成巨大的经济负担。据报道,葛根素具有降低血脂的作用,但由于 NAFLD 的复杂性,其具体作用机制尚不清楚。本研究旨在评估葛根素(饮食中 0.11%和 0.22%)对高脂肪高果糖饮食(HFFD)诱导的大鼠 NAFLD 的预防或改善作用。大鼠用 HFFD 混合葛根素喂养 20 周。结果表明,葛根素改善了血清和肝脏中的脂质水平。进一步探索其机制发现,葛根素通过降低 、 、 、 、 、 、 、 和 的表达,上调 、 和 的表达,改善 NAFLD 大鼠的肝脂质蓄积。同时,葛根素给药后,血清和肝脏中的抗氧化标志物(超氧化物歧化酶、谷胱甘肽过氧化物酶和过氧化氢酶)水平显著升高,血清和肝脏中炎症因子(白细胞介素-18、白细胞介素-1β和肿瘤坏死因子α)的含量明显降低。此外,葛根素还可以改善肝功能。总之,葛根素通过调节肝脂质蓄积、肝功能、氧化应激和炎症改善 HFFD 诱导的 NAFLD。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a9f/9359096/4aaba7198650/fimmu-13-956688-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a9f/9359096/51576bb75210/fimmu-13-956688-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a9f/9359096/ed350795da48/fimmu-13-956688-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a9f/9359096/f9e48a8f5861/fimmu-13-956688-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a9f/9359096/e9414612a33d/fimmu-13-956688-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a9f/9359096/33f9e251f441/fimmu-13-956688-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a9f/9359096/92021d9fc235/fimmu-13-956688-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a9f/9359096/c06e5529fe96/fimmu-13-956688-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a9f/9359096/cb57d22df113/fimmu-13-956688-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a9f/9359096/4aaba7198650/fimmu-13-956688-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a9f/9359096/51576bb75210/fimmu-13-956688-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a9f/9359096/ed350795da48/fimmu-13-956688-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a9f/9359096/f9e48a8f5861/fimmu-13-956688-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a9f/9359096/e9414612a33d/fimmu-13-956688-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a9f/9359096/33f9e251f441/fimmu-13-956688-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a9f/9359096/92021d9fc235/fimmu-13-956688-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a9f/9359096/c06e5529fe96/fimmu-13-956688-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a9f/9359096/cb57d22df113/fimmu-13-956688-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a9f/9359096/4aaba7198650/fimmu-13-956688-g009.jpg

相似文献

1
Puerarin ameliorates nonalcoholic fatty liver in rats by regulating hepatic lipid accumulation, oxidative stress, and inflammation.葛根素通过调节肝脂质蓄积、氧化应激和炎症改善大鼠非酒精性脂肪肝。
Front Immunol. 2022 Jul 25;13:956688. doi: 10.3389/fimmu.2022.956688. eCollection 2022.
2
Sesamin ameliorates hepatic steatosis and inflammation in rats on a high-fat diet via LXRα and PPARα.芝麻素通过肝X受体α(LXRα)和过氧化物酶体增殖物激活受体α(PPARα)改善高脂饮食大鼠的肝脏脂肪变性和炎症。
Nutr Res. 2016 Sep;36(9):1022-1030. doi: 10.1016/j.nutres.2016.06.015. Epub 2016 Jun 27.
3
Pueraria lobata antioxidant extract ameliorates non-alcoholic fatty liver by altering hepatic fat accumulation and oxidative stress.野葛抗氧化提取物通过改变肝脏脂肪堆积和氧化应激来改善非酒精性脂肪肝。
J Ethnopharmacol. 2024 Oct 28;333:118468. doi: 10.1016/j.jep.2024.118468. Epub 2024 Jun 19.
4
Corn peptides improved obesity-induced non-alcoholic fatty liver disease through relieving lipid metabolism, insulin resistance and oxidative stress.玉米肽通过改善脂代谢、胰岛素抵抗和氧化应激改善肥胖诱导的非酒精性脂肪肝。
Food Funct. 2022 May 23;13(10):5782-5793. doi: 10.1039/d2fo00199c.
5
Chitosan Oligosaccharide Attenuates Nonalcoholic Fatty Liver Disease Induced by High Fat Diet through Reducing Lipid Accumulation, Inflammation and Oxidative Stress in C57BL/6 Mice.壳寡糖通过减少 C57BL/6 小鼠的脂肪积累、炎症和氧化应激来减轻高脂饮食诱导的非酒精性脂肪肝病。
Mar Drugs. 2019 Nov 16;17(11):645. doi: 10.3390/md17110645.
6
A multi-targeting strategy to ameliorate high-fat-diet- and fructose-induced (western diet-induced) non-alcoholic fatty liver disease (NAFLD) with supplementation of a mixture of legume ethanol extracts.采用多靶点策略,通过补充豆类乙醇提取物混合物来改善高脂肪饮食和果糖诱导的(西式饮食诱导的)非酒精性脂肪性肝病(NAFLD)。
Food Funct. 2020 Sep 23;11(9):7545-7560. doi: 10.1039/d0fo01405b.
7
Adzuki bean ameliorates hepatic lipogenesis and proinflammatory mediator expression in mice fed a high-cholesterol and high-fat diet to induce nonalcoholic fatty liver disease.小豆可改善喂食高胆固醇和高脂肪饮食以诱导非酒精性脂肪性肝病的小鼠的肝脏脂肪生成和促炎介质表达。
Nutr Res. 2016 Jan;36(1):90-100. doi: 10.1016/j.nutres.2015.11.002. Epub 2015 Nov 10.
8
Raspberry ketone ameliorates nonalcoholic fatty liver disease in rats by activating the AMPK pathway.覆盆子酮通过激活 AMPK 通路改善大鼠非酒精性脂肪性肝病。
Eur J Pharmacol. 2023 Oct 15;957:176001. doi: 10.1016/j.ejphar.2023.176001. Epub 2023 Aug 19.
9
[Protective effect of corn peptide on nonalcoholic fatty liver disease in rats induced by high fat diet].[玉米肽对高脂饮食诱导的大鼠非酒精性脂肪性肝病的保护作用]
Wei Sheng Yan Jiu. 2023 Mar;52(2):239-245. doi: 10.19813/j.cnki.weishengyanjiu.2023.02.011.
10
Black Sesame Seeds Ethanol Extract Ameliorates Hepatic Lipid Accumulation, Oxidative Stress, and Insulin Resistance in Fructose-Induced Nonalcoholic Fatty Liver Disease.黑芝麻乙醇提取物改善果糖诱导的非酒精性脂肪肝病中的肝脂质蓄积、氧化应激和胰岛素抵抗。
J Agric Food Chem. 2018 Oct 10;66(40):10458-10469. doi: 10.1021/acs.jafc.8b04210. Epub 2018 Oct 2.

引用本文的文献

1
Potential Applications and Risks of Supranutritional Selenium Supplementation in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Critical Review.超营养剂量补充硒在代谢功能障碍相关脂肪性肝病中的潜在应用与风险:一项批判性综述
Nutrients. 2025 Jul 30;17(15):2484. doi: 10.3390/nu17152484.
2
Puerarin as a multi-targeted modulator of lipid metabolism: molecular mechanisms, therapeutic potential and prospects for nutritional translation.葛根素作为脂质代谢的多靶点调节剂:分子机制、治疗潜力及营养转化前景
Front Nutr. 2025 Jul 18;12:1598897. doi: 10.3389/fnut.2025.1598897. eCollection 2025.
3
Gut microbiota modulation by Traditional Chinese Medicine: a translational strategy for metabolic dysfunction-associated steatotic liver disease.

本文引用的文献

1
Dietary Supplementation of Polysaccharides Alleviate Nutritional Obesity in Mice via Regulating Inflammatory Response and Lipid Metabolism.膳食补充多糖通过调节炎症反应和脂质代谢减轻小鼠营养性肥胖。
Foods. 2022 Mar 24;11(7):942. doi: 10.3390/foods11070942.
2
Isorhamnetin attenuates high-fat and high-fructose diet induced cognitive impairments and neuroinflammation by mediating MAPK and NFκB signaling pathways.山奈酚通过调控 MAPK 和 NFκB 信号通路减轻高脂高果糖饮食诱导的认知障碍和神经炎症。
Food Funct. 2021 Oct 4;12(19):9261-9272. doi: 10.1039/d0fo03165h.
3
Sphingolipids as a Culprit of Mitochondrial Dysfunction in Insulin Resistance and Type 2 Diabetes.
中药对肠道微生物群的调节作用:代谢功能障碍相关脂肪性肝病的转化策略
Front Pharmacol. 2025 Jun 10;16:1600439. doi: 10.3389/fphar.2025.1600439. eCollection 2025.
4
Puerarin Delays the Progression of Muscle Atrophy in Mice With Dexamethasone-Induced Sarcopenia Through Inhibiting the TNF-α/NF-κB Pathway.葛根素通过抑制TNF-α/NF-κB信号通路延缓地塞米松诱导的小鼠肌肉减少症的肌肉萎缩进展
Food Sci Nutr. 2025 Apr 18;13(4):e70166. doi: 10.1002/fsn3.70166. eCollection 2025 Apr.
5
Flavonoids in natural products for the therapy of liver diseases: progress and future opportunities.用于肝病治疗的天然产物中的黄酮类化合物:进展与未来机遇
Front Pharmacol. 2024 Oct 24;15:1485065. doi: 10.3389/fphar.2024.1485065. eCollection 2024.
6
Metabolic-Associated Fatty Liver Disease: The Influence of Oxidative Stress, Inflammation, Mitochondrial Dysfunctions, and the Role of Polyphenols.代谢相关脂肪性肝病:氧化应激、炎症、线粒体功能障碍的影响及多酚的作用
Pharmaceuticals (Basel). 2024 Oct 10;17(10):1354. doi: 10.3390/ph17101354.
7
Possible protective effect of natural flavanone naringenin-reduced graphene oxide nanosheets on nonalcoholic fatty liver disease.天然黄酮柚皮素还原氧化石墨烯纳米片对非酒精性脂肪性肝病可能的保护作用
Naunyn Schmiedebergs Arch Pharmacol. 2025 Apr;398(4):4071-4086. doi: 10.1007/s00210-024-03495-9. Epub 2024 Oct 16.
8
Puerarin: a hepatoprotective drug from bench to bedside.葛根素:一种从实验室到临床的保肝药物。
Chin Med. 2024 Oct 8;19(1):139. doi: 10.1186/s13020-024-01011-y.
9
Mechanism of Metabolic Dysfunction-associated Steatotic Liver Disease: Important role of lipid metabolism.代谢功能障碍相关脂肪性肝病的发病机制:脂质代谢的重要作用。
J Clin Transl Hepatol. 2024 Sep 28;12(9):815-826. doi: 10.14218/JCTH.2024.00019. Epub 2024 Sep 3.
10
Puerarin ameliorates non-alcoholic fatty liver disease by inhibiting lipid metabolism through FMO5.葛根素通过FMO5抑制脂质代谢改善非酒精性脂肪性肝病。
Front Pharmacol. 2024 Jul 11;15:1423634. doi: 10.3389/fphar.2024.1423634. eCollection 2024.
鞘脂类作为胰岛素抵抗和 2 型糖尿病中线粒体功能障碍的罪魁祸首。
Front Endocrinol (Lausanne). 2021 Mar 18;12:635175. doi: 10.3389/fendo.2021.635175. eCollection 2021.
4
Puerarin improves hepatic glucose and lipid homeostasis in vitro and in vivo by regulating the AMPK pathway.葛根素通过调节 AMPK 通路改善体内外肝糖和脂代谢平衡。
Food Funct. 2021 Mar 21;12(6):2726-2740. doi: 10.1039/d0fo02761h. Epub 2021 Mar 8.
5
Hepatic lipid droplets: A balancing act between energy storage and metabolic dysfunction in NAFLD.肝内脂滴:NAFLD 中能量储存与代谢功能障碍之间的平衡作用。
Mol Metab. 2021 Aug;50:101115. doi: 10.1016/j.molmet.2020.101115. Epub 2020 Nov 10.
6
Anti-inflammatory activities of puerarin in high-fat diet-fed rats with streptozotocin-induced gestational diabetes mellitus.葛根素对高脂肪饮食喂养的链脲佐菌素诱导妊娠期糖尿病大鼠的抗炎作用。
Mol Biol Rep. 2020 Oct;47(10):7537-7546. doi: 10.1007/s11033-020-05816-6. Epub 2020 Sep 18.
7
NAFLD and Statins.非酒精性脂肪性肝病与他汀类药物
Dig Dis Sci. 2020 Oct;65(10):3052-3053. doi: 10.1007/s10620-020-06505-x. Epub 2020 Aug 14.
8
Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease.氧化应激在非酒精性脂肪性肝病发病机制中的作用。
Free Radic Biol Med. 2020 May 20;152:116-141. doi: 10.1016/j.freeradbiomed.2020.02.025. Epub 2020 Mar 8.
9
Cardiac ketone body metabolism.心脏酮体代谢。
Biochim Biophys Acta Mol Basis Dis. 2020 Jun 1;1866(6):165739. doi: 10.1016/j.bbadis.2020.165739. Epub 2020 Feb 19.
10
The 20% Rule of NASH Progression: The Natural History of Advanced Fibrosis and Cirrhosis Caused by NASH.非酒精性脂肪性肝炎(NASH)进展的20%规则:NASH所致晚期纤维化和肝硬化的自然史
Hepatology. 2019 Dec;70(6):1885-1888. doi: 10.1002/hep.30946.